EVE CUSICK: Open Payments
NPI 1891145330 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,991 in 116 payments from 18 companies in 2025. Trend: 2023 $792 · 2024 $1,681 · 2025 $1,991
Food & beverage: $1,991
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $577 |
| GlaxoSmithKline, LLC. | 31 | $371 |
| Amgen Inc. | 13 | $135 |
| HARMONY BIOSCIENCES LLC | 7 | $119 |
| Verona Pharma, Inc. | 5 | $101 |
| Grifols USA, LLC | 5 | $97 |
| Insmed, Inc. | 6 | $95 |
| Philips North America LLC | 5 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| United Therapeutics Corporation | 4 | $68 |
Products named: TEZSPIRE, NUCALA, TRELEGY ELLIPTA, FASENRA, WAKIX, Ohtuvayre, Prolastin-C Liquid, Arikayce.
Industry payments across NJ — which companies pay providers there.
